Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.

Prognostic implications of EGFR protein expression in sporadic colorectal tumors: Correlation with copy number status, mRNA levels and miRNA regulation

Open access
del Carmen, Sofía, Corchete, Luís Antonio, Gervas, Ruth, Rodriguez, Alba, Garcia, María, Álcazar, José Antonio, García, Jacinto, Bengoechea, Oscar, Muñoz-Bellvis, Luis, Sayagués, José María, Abad, Mar · 2020 · Scientific Reports

Abstract

Sporadic colorectal cancer (sCRC) is the third most frequent cancer worldwide and the second most common cause of cancer-related deaths (mainly due metastatic dissemination). We investigated the immunohistochemical expression of frequently altered proteins in primary tumors from 51 patients (25 liver metastatic and 26 non-metastatic cases) with a median 103 months follow-up (103 months). We evaluated EGFR copy number (using SNP arrays and FISH) and its expression and regulation (by mRNA and miRNA arrays). We found differences between metastatic and non-metastatic sCRCs for MLH1 (p = 0.05), PMS2 (p = 0.02), CEA (p < 0.001) and EGFR (p < 0.001) expression. EGFR expression was associated with lymph node metastases (p = 0.001), liver metastases at diagnosis (p < 0.001), and advanced stage (p < 0.001). There were associations between EGFR expression-, EGFR gene copy number- and EGFR mRNA levels. We found potential interactions of two miRNAs targeting EGFR expression, (miR-134 and miR-4328, in non-metastatic and metastatic tumors, respectively). EGFR expression was associated with a worse outcome (p = 0.005). Multivariate analysis of prognostic factors for overall survival identified that, the expression of EGFR expression (p = 0.047) and pTNM stage (p < 0.001) predicted an adverse outcome. EGFR expression could be regulated by amplification or polysomies (in metastatic tumors), or miRNAs (miRNA-134, in non-metastatic tumors). EGFR expression in sCRC appears to be related to metastases and poor outcome.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-020-61688-7

Cites

73 of 73 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Clinical, biological and immunohistochemical markers of sCRC patients showing the impact on overall survival in the univariate analysis: (A) Age, (B) gender, (C) site of primary tumor, (D) TNM stage at diagnosis, (E) tumor size, (F) carcinoembryonic antigen (CEA) serum levels, (G) microsatellite instability, (H) EGFR expression, (I) β-catenin expression, (J) CEA expression, (K) c-Myc expression, (M) Her2 expression, (N) Ki-67 expression, and (O) p53 expression.
Figure 1 Clinical, biological and immunohistochemical markers of sCRC patients showing the impact on overall survival in the univariate analysis: (A) Age, (B) gender, (C) site of primary tumor, (D) TNM stage at diagnosis, (E) tumor size, (F) carcinoembryonic antigen (CEA) serum levels, (G) microsatellite instability, (H) EGFR expression, (I) β-catenin expression, (J) CEA expression, (K) c-Myc expression, (M) Her2 expression, (N) Ki-67 expression, and (O) p53 expression.CC BY · PubMed Central
Figure 2 Copy number alterations (CNAs) and EGFR gene expression levels detected in primary tumors from patients with metastatic and non-metastatic sCRC. CNA status assessed by Affymetrix 500‐K single nucleotide polymorphism (SNP)‐array platform (panel A) and FISH techniques [probes for identifying chromosome 7 centromere (7p11; green spots) and EGFR gene (7p11.2; red spots)] (panel B). EGFR gene expression profile analyzed by oligonucleotide arrays (Affymetrix PrimeView Human Gene Expression microarray) (panel C) and immunostaining techniques (20x) (panel D). Panel (B,D) correspond to a sample of the same patient.
Figure 2 Copy number alterations (CNAs) and EGFR gene expression levels detected in primary tumors from patients with metastatic and non-metastatic sCRC. CNA status assessed by Affymetrix 500‐K single nucleotide polymorphism (SNP)‐array platform (panel A) and FISH techniques [probes for identifying chromosome 7 centromere (7p11; green spots) and EGFR gene (7p11.2; red spots)] (panel B). EGFR gene expression profile analyzed by oligonucleotide arrays (Affymetrix PrimeView Human Gene Expression microarray) (panel C) and immunostaining techniques (20x) (panel D). Panel (B,D) correspond to a sample of the same patient.CC BY · PubMed Central
Figure 3 Correlation between EGFR gene expression using oligonucleotide arrays and CNA by SNP arrays in patients with sporadic colorectal cancer at diagnosis. The graphs show the regression lines for Y as a function of X (solid line) and for X as a function of Y (dashed line). If these regression lines are approximately perpendicular, it indicates that X and Y are not linearly correlated. The closer the lines, the greater the correlation.
Figure 3 Correlation between EGFR gene expression using oligonucleotide arrays and CNA by SNP arrays in patients with sporadic colorectal cancer at diagnosis. The graphs show the regression lines for Y as a function of X (solid line) and for X as a function of Y (dashed line). If these regression lines are approximately perpendicular, it indicates that X and Y are not linearly correlated. The closer the lines, the greater the correlation.CC BY · PubMed Central
Figure 4 Hierarchical cluster analysis based on EGFR expression regulated by 98 miRNAs present in our array (out of 134 miRNAs total candidates) of the non-metastatic (n = 25) and metastatic cases (n = 26) included in the study.
Figure 4 Hierarchical cluster analysis based on EGFR expression regulated by 98 miRNAs present in our array (out of 134 miRNAs total candidates) of the non-metastatic (n = 25) and metastatic cases (n = 26) included in the study.CC BY · PubMed Central
Figure 5 Validation of the impact of EGFR expression on overall survival in an independent series of sCRC patients from the GEO database (n = 32): panel (A), EGFR expression showing the impact on overall survival; panel (B), EGFR gene expression levels detected in primary tumors from patients with metastatic and non-metastatic sCRC; and panel (C), correlation between EGFR gene expression using oligonucleotide arrays and CNA by SNP arrays in patients with sporadic colorectal cancer at diagnosis.
Figure 5 Validation of the impact of EGFR expression on overall survival in an independent series of sCRC patients from the GEO database (n = 32): panel (A), EGFR expression showing the impact on overall survival; panel (B), EGFR gene expression levels detected in primary tumors from patients with metastatic and non-metastatic sCRC; and panel (C), correlation between EGFR gene expression using oligonucleotide arrays and CNA by SNP arrays in patients with sporadic colorectal cancer at diagnosis.CC BY · PubMed Central
Figure 6 TMA: (A) TMA paraffin block; (B) TMA slide, hematoxylin-eosin; (C) hematoxylin-eosin panoramic view, 3-µm section.
Figure 6 TMA: (A) TMA paraffin block; (B) TMA slide, hematoxylin-eosin; (C) hematoxylin-eosin panoramic view, 3-µm section.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 73 references

Research works printed but not linked: 2

  1. Kaserer, K. et al. Staining patterns of p53 immunohistochemistry and their biological significance in colorectal cancer. J. Pathol. 190(4), 450–6 (2000). · doi:10.1002/(sici)1096-9896(200003)190:4<450::aid-path545>3.0.co;2-8
  2. Goldstein, N. S. & Armin, M. Epidermal growth factor receptor immunohistochemical reactivity in patients with American Joint Committee on Cancer Stage IV colon adenocarcinoma: implications for a standardized scoring system. Cancer 92(5), 1331–46 (2001). · DOI · Paper page

Cited by

See all 24

Metadata

Authors
del Carmen, S., Corchete, L. A., Gervas, R., Rodriguez, A., Garcia, M., Álcazar, J. A., García, J., Bengoechea, O., Muñoz-Bellvis, L., Sayagués, J. M., & Abad, M.
Affiliations
Universidad de Salamanca (ES)
Corresponding author
  • Sayagués, José María
  • Abad, Mar
Venue
Scientific Reports
Published
2020-03-13
Volume
10
Issue
1
Pages
4662-4662
ISSN
2045-2322 (ISSN-L)
OpenAlex
W3011667214
Cited by
18
References
73
Citations by year
2025: 1 · 2024: 1 · 2023: 5 · 2022: 6 · 2021: 3 · 2020: 2
FWCI
1.81
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Hispana (publishedVersion, cc-by-nc-nd)
  • Gredos (University of Salamanca) (submittedVersion, cc-by-nc-nd)
Funders
  • Centro de Investigación Biomédica en Red de Cáncer (CB16/12/00400)
  • Instituto de Salud Carlos III (CB16/12/00400)
Topics
  • Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
  • Health Sciences › Medicine › Oncology › HER2/EGFR in Cancer Research
Keywords
sporadic colorectal cancer, EGFR expression, EGFR gene copy number, microRNA regulation, miR-134, liver metastasis, lymph node metastasis, prognostic factors, overall survival, MLH1, PMS2, CEA, gene amplification, polysomy, TNM stage
MeSH terms
Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Neoplasm Metastasis, Neoplasm Staging, Prognosis, Colorectal Neoplasms, Gene Expression Regulation, Neoplastic, Survival Analysis, Gene Expression Profiling, MicroRNAs, DNA Copy Number Variations, ErbB Receptors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prognostic implications of EGFR protein expression in sporadic colorectal tumors: Correlation with copy number status, mRNA levels and miRNA regulation. https://app.cochat.ai/papers/10.1038/s41598-020-61688-7
The paper
del Carmen, S., Corchete, L. A., Gervas, R., Rodriguez, A., Garcia, M., Álcazar, J. A., García, J., Bengoechea, O., Muñoz-Bellvis, L., Sayagués, J. M., & Abad, M. (2020). Prognostic implications of EGFR protein expression in sporadic colorectal tumors: Correlation with copy number status, mRNA levels and miRNA regulation. Scientific Reports. https://doi.org/10.1038/s41598-020-61688-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.